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Abstract 29 
The isoleucine conjugate of 12-oxo-phytodienoic acid (OPDA-Ile), a new member of the 30 
jasmonate family, was recently identified in Arabidopsis thaliana and might be a signaling molecule 31 
in plants. However, the biosynthesis and function of OPDA-Ile remains elusive. This study reports an 32 
in vitro enzymatic method for synthesizing OPDA-Ile, which is catalyzed by reactions of lipoxygenase 33 
(LOX), allene oxide synthase (AOS), and allene oxide cyclase (AOC) using isoleucine conjugates of 34 
-linolenic acid (LA-Ile) as the substrate. A. thaliana fed LA-Ile exhibited a marked increase in the 35 
OPDA-Ile concentration. LA-Ile was also detected in A. thaliana. Furthermore, stable isotope labelled 36 
LA-Ile was incorporated into OPDA-Ile. Thus, OPDA-Ile is biosynthesized via the cyclization of LA-37 
Ile in A. thaliana.  38 
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Plants have a wide variety of physiological responses that allow them to adapt to adverse 43 
environmental conditions that negatively affect their growth and development. Jasmonic acid (JA, 1) 44 
plays important roles in stress responses and development in plants. JA (1) functions as a signaling 45 
molecule in numerous plant physiological processes related to development and defense responses.1 46 
Most enzymes that participate in JA (1) biosynthesis have been successfully characterized. JA (1) has 47 
been shown to be a signaling molecule in both flowering plants and a model lycophyte, Selaginella 48 
moellendorffii.2 JA (1) is a ubiquitous phytohormone detected in vascular plant species. 49 
    The JA (1) biosynthetic pathway begins with the lipase-mediated release of α-linolenic acid (2) 50 
from the membrane lipids of chloroplasts (Fig. 1).1 In chloroplasts, lipoxygenase (LOX) oxidizes α-51 
linolenic acid (2) into 13(S)-hydroperoxy octadecatrienoic acid (13-HPOT, 3). 13-HPOT (3) is 52 
metabolized by allene oxide synthase (AOS) into an unstable allene oxide (12,13-EOT, 4), which is 53 
cyclized by allene oxide cyclase (AOC) into cis-(+)-12-oxo-phytodienoic acid (OPDA, 5). The AOC 54 
reaction provides two side chain configurations in the naturally occurring jasmonate structure. 55 
Reduction of the 10,11-double bond in OPDA (5) by OPDA reductase 3 (OPR3) then yields 3-oxo-2-56 
 
 
(2-cis-pentenyl)cyclopentane-1-octanoic acid (OPC-8:0, 6). Three β-oxidation steps convert OPC-8:0 57 
(6) into (+)-7-iso-JA (7), which is naturally isomerized to (−)-JA (1). JA (1) is converted to the 58 
isoleucine conjugate of JA (JA-Ile, 8) by JAR1. JA-Ile (8) is considered a versatile signaling compound 59 
in the JA signaling pathway.1,3 JA-Ile (8) binds to its receptor, coronatine insensitive 1 (COI1), and 60 
then mediates the binding of the JAZ protein to the COI1-JA-Ile unit of the skp-cullin-F box (SCF) 61 
complex, resulting in degradation by the 26S proteasome and the subsequent induction of COI1-62 
dependent JA responses.4-6 OPDA (5) is not only an intermediate in the JA biosynthetic pathway but 63 
also exerts individual JA (1)-independent biological functions.7-9 OPDA (5) binds cyclophilin 20-3, 64 
leading to enhanced redox capability in Arabidopsis thaliana.10 In contrast, OPDA (5), but not JA (1), 65 
is present in the model bryophytes Marchantia polymorpha and Physcomitrella patens, with functions 66 
in defense and development.11-13 However, the detailed mechanism of the OPDA signaling system 67 
remains unknown. 68 
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Fig. 1. Octadecanoid pathway. 70 
 71 
 72 
OPDA-Ile (9), a new member of the jasmonate family, was recently identified in A. thaliana.14 73 
Moreover, OPDA-Ile (9) induces the expression of the ZAT10 gene, which encodes a salt tolerance 74 
 
 
zinc finger protein, and the GRX480 gene, which encodes a GLUTAREDOXIN.15,16 Based on these 75 
findings, OPDA-Ile (9) may function as a signaling molecule in plants. The OPDA-Ile (9) biosynthetic 76 
mechanism has not yet been determined, whereas the A. thaliana jar1 mutant, which lacks the jar1 77 
gene encoding a protein that catalyzes the conjugation of JA (1) with Ile, produces OPDA-Ile (9).16 78 
Thus, the OPDA-Ile (9) biosynthetic pathway, which is independent of JAR1, is proposed to be present 79 
in A. thaliana. 80 
The biological functions of OPDA-Ile (9) remain elusive. An efficient method for synthesizing 81 
OPDA-Ile (9) should be developed to investigate the detailed biological activities of this compound. 82 
OPDA-Ile (9) was previously produced via the chemical conjugation of Ile and OPDA (5) under 83 
alkaline conditions.16,17 The stereochemistry of the two side chains of OPDA (5) is easily converted 84 
from the cis-form to trans-form under alkaline conditions; therefore, the previously reported method 85 
for synthesizing OPDA-Ile (9) is not necessarily optimal. For OPDA (5) biosynthesis, reactions with 86 
LOX, AOS and AOC occur on the unsaturated alkyl chains of α-linolenic acid (2), 13-HPOT (3), and 87 
12,13-EOT (4), respectively.18-20 Analysis of the crystal structures of AOS and AOC suggests that 88 
unsaturated alkyl chains of 13-HPOT (3) and 12,13-EOT (4) are present in the active sites of the 89 
corresponding enzymes.18,19  90 
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Fig. 2. In vitro enzymatic synthesis of OPDA-Ile (9). LA-Ile (10) was incubated in the reaction mixture 92 
[50 mM Tris-HCl (pH 8.0), flax seed extract, PpAOC2] at 25 °C for 1 hours. 93 
 94 
 95 
We attempted the in vitro cyclization of LA-Ile (10) to produce OPDA-Ile (9) by performing 96 
continuous reactions with LOX, AOS, and AOC according to the method for in vitro stereoselective 97 
OPDA (5) synthesis (Fig. 2).21 The mixture used for the in vitro synthesis of OPDA-Ile (10) contained 98 
flaxseed extract, recombinant PpAOC2 derived from the model moss Physcomitrella patens, and LA-99 
 
 
Ile (10) and was incubated at 25 °C for 1 hour. As a result, 11 mg of OPDA-Ile (9) was successfully 100 
synthesized from 30 mg of LA-Ile (10) with a 35% yield (Supplemental data). Analysis of the AOS 101 
crystal structure suggests that a lysine residue of AOS near the substrate interacts with the carboxyl 102 
group of 13-HPOT (3), thereby playing an important role in its binding.18 While the carboxyl group in 103 
linolenic acid (2) is replaced by an amide bond in LA-Ile (10), a lysine residue near the substrate of 104 
AOS may interact with the oxygen of the amide bond in a possible LOX product of LA-Ile (10). The 105 
alkyl chain of Ile moiety derived from LA-Ile (10) must not interfere with binding to LOX, AOS, or 106 
AOC. Therefore, the cyclization of LA-Ile (10) into OPDA-Ile (9) is found to have occurred. 107 
Additionally, the in vitro enzymatic synthesis of OPDA-Ile (9) was conducted under mild conditions 108 
and efficiently yielded OPDA-Ile (9). Considering the mechanisms of the LOX, AOS, and AOC 109 
reactions, the method reported in this study could be applied to the synthesis of other amino acid 110 
conjugates of OPDA. 111 
The biosynthetic mechanism of OPDA-Ile (9) was not revealed until recently. Two possibilities 112 
exist for the OPDA-Ile (9) biosynthetic pathway. One possibility is that OPDA-Ile (9) is synthesized 113 
by a protein that conjugates OPDA (5) and Ile. In the case of JA-Ile (8), a GH3 protein, JAR1 114 
conjugates JA (1) and Ile.1 A protein from the GH3 protein family is predicted to catalyze the 115 
conjugation of OPDA (5) and Ile. The other possibility is that OPDA-Ile (9) is biosynthesized by three 116 
continuous reactions with LOX, AOS, and AOC with LA-Ile (10) as the substrate, similar to the in 117 
vitro enzymatic synthesis of OPDA-Ile (9). In a previous study, the marginal conversion of OPDA into 118 
OPDA-Ile was observed in WS.15 The in vitro enzymatic synthesis of OPDA-Ile (9) in this study 119 
supports the hypothesis that OPDA-Ile (9) is biosynthesized from LA-Ile (10) via LOX-, AOS-, and 120 
AOC-mediated reactions in plants. A. thaliana plants grown for 30 days under short-day conditions 121 
were treated with 100 M LA-Ile (10) or OPDA (5), and the accumulation of OPDA-Ile (9) was 122 
analyzed by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). 123 
Based on the analytical data, the application of LA-Ile (10) significantly increased the OPDA-Ile (9) 124 
concentration in A. thaliana. The amount of OPDA-Ile (9) in plants treated with LA-Ile (10) was 125 
greater than that in untreated plants (Fig. 3). In contrast, the OPDA (5) treatment did not increase the 126 
OPDA-Ile (9) concentration (Fig. 3). These results suggested that OPDA-Ile (9) was biosynthesized 127 
 
 
from LA-Ile (10) but not OPDA (5). 128 
 129 
Fig. 3. UPLC-MS/MS analysis of OPDA-Ile (9) in A. thaliana treated with OPDA (5) or LA-Ile (10). 130 
Plants were treated with either 100 M LA-Ile (10) or OPDA (5). OPDA-Ile (9) was analyzed by 131 
UPLC-MS/MS. The MRM mode was used to analyze a specific fragment peak at m/z 130.00 [M−H]− 132 
derived from the peak at m/z 404.28 [M−H]−. Each value is represented by the mean ± SD of five 133 
independent biological replicates. Student’s t-test, ***p < 0.001. 134 
 135 
 136 
As described above, OPDA-Ile (9) was postulated to be converted from LA-Ile (10); however, LA-137 
Ile (10) has not been reported as a natural product. A. thaliana was analyzed by liquid chromatography-138 
tandem mass spectrometry (LC-MS/MS) to determine the presence of LA-Ile (10). The analytical data 139 
revealed a predominant peak derived from LA-Ile (10) in the chromatogram of an A. thaliana extract 140 
(Fig. 4). The retention time of the peak was the same as the peak for the LA-Ile (10) standard. Thus, 141 
LA-Ile (10 pmol/g FW, 10) is present in A. thaliana. To our knowledge, this report represents the first 142 
evidence identifying LA-Ile (10) as a natural product. 143 
 144 
 
 
 145 
Fig. 4. Analysis of LA-Ile (10) in A. thaliana. LA-Ile (10) was analyzed by LC-MS/MS. The MRM 146 
mode was used to analyze a specific fragment peak at m/z 128.0 [M−H]− derived from the peak at m/z 147 
390.3 [M−H]−. (A): standard; (B): plant extract. 148 
 149 
 150 
To examine whether OPDA-Ile (9) was synthesized by an A. thaliana protein extract, a reaction 151 
mixture comprising LA-Ile (10) and an A. thaliana protein extract was incubated for 1 hour, and then 152 
the reaction mixture was analyzed for the presence of OPDA-Ile (9) by UPLC-MS/MS. The peak 153 
derived from OPDA-Ile (9) appeared clearly in the reaction mixture of LA-Ile (10) and the protein 154 
extract (Fig. 5). In contrast, no clear peak derived from OPDA-Ile (10) was detected in the protein 155 
extract lacking LA-Ile (10) or in the buffer used to generate the protein extract supplemented with LA-156 
Ile (10) (Fig. 5). Arabidopsis protein extract was shown to exhibit sequential LOX, AOS, and AOC 157 
enzymatic activities to convert LA-Ile (10) into OPDA-Ile (9).  158 
 159 
 
 
 160 
Fig. 5. In vitro synthesis of OPDA-Ile (9) by protein extracts from A. thaliana. LA-Ile (10) was 161 
incubated with a protein extract prepared from A. thaliana at 25 C for 1 hour, and the mixture was 162 
then analyzed for OPDA-Ile (9) by UPLC-MS/MS. The MRM mode was used to analyze a specific 163 
fragment peak at m/z 130.00 [M−H]− derived from the peak at m/z 404.28 [M−H]−. (A): standard 164 
OPDA-Ile (9); (B): LA-Ile (10) in protein extract; (C): protein extract without added LA-Ile (10); (D): 165 
LA-Ile (10) in the buffer used for protein extraction. 166 
 167 
 168 
Next, we investigated whether stable-isotope-labelled LA-Ile (9) was incorporated into OPDA-Ile 169 
(9). LA-[13C6,15N]Ile was fed to A. thaliana, and OPDA-[13C6,15N]Ile in A. thaliana was then analyzed 170 
by UPLC-MS/MS. The analytical data showed that the peak derived from OPDA-[13C6,15N]Ile (m/z 171 
411>137) clearly appeared, and the retention time of OPDA-[13C6,15N]Ile was in accordance with that 172 
of non-labelled OPDA-Ile (m/z 414>130) (Fig. 5). Accordingly, OPDA-Ile (9) is biosynthesized via 173 
cyclization of the LA-Ile (10) substrate in A. thaliana. 174 
 175 
 
 
 176 
Fig. 5. Incorporation of LA-[13C6,15N]Ile into OPDA-[13C6,15N]Ile into A. thaliana. Plants were treated 177 
with or without 100 M LA-[13C6,15N]Ile, and the resulting mixture was analyzed for OPDA-178 
[13C6,15N]Ile by UPLC-MS/MS. The MRM mode was used to analyze a specific fragment peak of 179 
OPDA-[13C6,15N]Ile at m/z 137.00 [M−H]− derived from the peak at m/z 411.28 [M−H]− and a specific 180 
fragment peak of OPDA-Ile at m/z 130.00 [M−H]− derived from the peak at m/z 404.28 [M−H]−. (A); 181 
extract of plant treated with LA-[13C6,15N]Ile: (B); extract of control plant. 182 
 183 
 184 
Based on the data described above, OPDA-Ile (9) is biosynthesized in A. thaliana via LOX-, AOS-, 185 
and AOC-mediated reactions, which participate in the octadecanoid pathway, using LA-Ile (10) as the 186 
substrate. This result is supported by previous studies showing that the jar1 mutant still produces 187 
OPDA-Ile (9), that the aos mutant does not produce OPDA-Ile and that marginal conversion of OPDA 188 
into OPDA-Ile occurs in A. thaliana.14,15 Because the three proteins, LOX, AOS and AOC, are 189 
localized in chloroplasts, OPDA-Ile (9) is predicted to be located in chloroplasts. Additionally, 190 
arabidopsides, monogalactosyl glycerol lipids containing OPDA,20 are likely synthesized by a 191 
combination of LOX-, AOS-, and AOC-mediated reactions using monogalactosyldiacylglycerol as the 192 
substrate.22 The previously reported data also support the results obtained in this study. Thus, the 193 
 
 
present study suggests that an -linolenic acid-related compound with a modified carboxylic acid can 194 
become a substrate in the octadecanoid pathway. It is possible that a variety of OPDA-related 195 
compounds are biosynthesized through the octadecanoid pathway in plants. 196 
As described above, LA-Ile (10) is a synthetic precursor of OPDA-Ile (9). LA-Ile (10) synthesis is 197 
also a crucial step in OPDA-Ile (9) biosynthesis; however, the conjugation mechanism of -linolenic 198 
acid (2) and Ile in A. thaliana remains unclear. As GH3 proteins conjugate amino acids and plant 199 
hormones, such as indole-3-acetic acid and JA (1),23 a member of the GH3 protein family likely plays 200 
an important role in OPDA-Ile (10) biosynthesis. The identification of an enzyme that catalyzes the 201 
conjugation of -linolenic acid (2) and Ile is required to elucidate the total biosynthetic pathway for 202 
OPDA-Ile (9).  203 
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Supplemental data 279 
1. General methods 280 
The 1H- and 13C-NMR spectra were recorded on a Jeol EX-270 NMR spectrometer (Jeol, Tokyo, 281 
Japan). 1H-NMR chemical shifts are referenced to the residual CDCl3 solvent peak at 7.24 ppm. 13C-282 
NMR chemical shifts are referenced to the residual CDCl3 solvent peak at 77.0 ppm. Field 283 
desorption-high resolution mass spectra (FD-HR-MS) were recorded on a JEOL JMS T100GCV mass 284 
spectrometer (Jeol, Tokyo, Japan). Specific rotation values were measured on a JASCO DIP-310 285 
polarimeter (Jasco Corporation, Tokyo, Japan). 286 
 287 
2. LA-Ile (10) synthesis 288 
-Linolenic acid (2, 0.88 mmol, 245 mg) was dissolved in tetrahydrofuran (11 ml) with 289 
trimethylamine (0.98 mmol, 0.14 ml). Chloroformic acid ethyl ester (0.1 mmol, 0.1 ml) was added 290 
while the mixture was stirred at −10 °C. After the resulting solution was stirred for 20 min, a 0.3 M 291 
aqueous NaOH solution (6.9 ml) containing Ile (1.77 mmol, 232 mg) was added to the solution and 292 
stirred for an additional 25 min at room temperature. After evaporation to remove the solvent, the 293 
obtained residue was cooled at 0 °C, and poured into 1 M HCl, extracted with ethyl acetate, and dried 294 
over Mg2SO4. The extract was evaporated and purified by SiO2 gel column chromatography (Kanto 295 
Chemical, Tokyo, Japan), which was developed with a mixed solvent of acetic acid/ethyl acetate/n-296 
hexane (1/30/70, v/v). LA-Ile (10) was obtained as a colorless oil (293.2 mg, 85%). FD-HR-MS: found 297 
m/z 392.3150 [M+H]+; calculated m/z 392.3165 for C24H42NO3; [α]25D +19.8 (c 0.3, CHCl3); 1H-NMR 298 
(CDCl3, 270 MHz) : 11.03 (s, 1H), 6.44 (d, J = 8.6 Hz, 1H), 5.38-5.21 (m, 6H), 4.59 (dd, J = 4.6, 8.6 299 
Hz, 1H), 2.77-2.73 (m, 4H), 2.22 (t, J = 8.1 Hz, 2H), 2.08-1.85 (m, 6H), 1.60-1.38 (m, 3H), 1.22-1.07 300 
(m, 8H), 0.97-0.81 (m, 9H). 301 
 302 
3. LA-[13C6,15N]Ile synthesis 303 
   Instead of Ile, [13C6,15N]Ile was conjugated to a-linolenic acid. The reaction was carried out 304 
according to the method described in the previous section. 305 
 
 
 306 
4. OPDA-[13C6,15N]Ile synthesis 307 
   Instead of LA-Ile (10), LA-[13C6,15N]Ile was cyclized to afford OPDA-[13C6,15N]Ile according to 308 
the method described in the previous section. 309 
 310 
4. In vitro enzymatic synthesis of OPDA-Ile (9) 311 
OPDA-Ile (9) was synthesized in vitro using LA-Ile (10) as the substrate, according to the method 312 
used for the in vitro synthesis of OPDA (5) (Kajiwara et al., 2012). The reaction mixture used for the 313 
in vitro synthesis of OPDA-Ile (9) contained a flaxseed extract, recombinant PpAOC2 and LA-Ile (10). 314 
An acetone powder of the flaxseed extract (625 mg) was extracted with 5 ml of 50 mM Tris-HCl buffer 315 
(pH 8.0, 20 mM NaCl) containing 500 g of recombinant PpAOC2 and then centrifuged at 21,500 × 316 
g for 30 min at 4 °C. The prepared enzyme solution was incubated with 30 mg of LA-Ile (10) and 317 
stirred under an oxygen atmosphere for 3 hours at room temperature. The reaction mixture was 318 
extracted with ethyl acetate. After the extract was evaporated, the resulting residue was purified by 319 
SiO2 gel column chromatography, which was developed with a mixed solvent of acetic acid/ethyl 320 
acetate/n-hexane (1/30/70, v/v) to obtain 11 mg of OPDA-Ile (9). [α]25D +42.3 (c 0.6, CHCl3). FD-321 
HR-MS: found m/z 404.2804 [M-H]; calculated m/z 404.2801 for C24H38NO4. 1H-NMR (CDCl3, 270 322 
MHz) : 7.74-7.70 (dd, J = 5.8, 2.6 Hz, 1H), 6.20-6.12 (dd, J = 3.1, 1.8 Hz, 1H), 6.08-5.98 (d, J = 8.3 323 
Hz, 1H), 5.48-5.28 (m, 2H), 4.64-4.54 (dd, J = 5.6, 4.8 Hz, 1H), 3.03-2.88 (m, 1H), 2.55-2.46 (m, 1H), 324 
2.46-2.36 (m, 1H), 2.26-2.17 (t, J = 7.4 Hz, 2H), 2.15-2.07 (m, 1H), 2.06-1.96 (m, 2H), 1.96-1.84 (m, 325 
1H), 1.77-1.65 (m, 1H), 1.64-1.54 (m, 2H), 1.53-1.40 (m, 1H), 1.34-1.24 (m, 6H),1.23-1.09 (m, 2H), 326 
1.05-0.72 (m, 11H). 13C-NMR (CDCl3, 67.5 MHz) : 208.8, 172.4, 171.1, 165.0, 130.5, 129.8, 124.3, 327 
53.8, 47.4, 41.8, 35.1, 34.0, 28.1, 27.0, 26.6, 26.5, 25.0, 23.1, 22.6, 21.2, 18.2, 12.7, 11.4, 9.0. 328 
 329 
5. Plants and chemical treatments 330 
A. thaliana (Col-0) was grown on soil under short day conditions (10 hours of light/14 hours of 331 
dark) at 25 °C for 30 days under a white fluorescent light. Plants were sprayed with 100 M OPDA 332 
and LA-Ile once per day for 3 days. For the feeding experiment with LA-[13C6,15N]Ile, A. thaliana was 333 
 
 
harvested at 12 hours after spraying 100 M LA-[13C6,15N]Ile. OPDA was synthesized according to 334 
the method reported by Kajiwara et al. (2012). 335 
 336 
6. Analysis of OPDA-Ile (9) 337 
A. thaliana plants were grown on Jiffy-7 (Sakata Seed Corporation, Yokohama, Japan) for 5 weeks 338 
at 22 °C under a white fluorescent light with 10 h/14 h photoperiods (short-day conditions). Samples 339 
were prepared according to the method developed by Floková et al. (Phytochemistry. 2016; 122: 230–340 
237). UPLC was performed using an ACQUITY UPLC system (Waters Corporation, Milford, MA, 341 
USA) equipped with a binary solvent manager and a sample manager. MS/MS was subsequently 342 
performed using a Micromass Quattro Premier tandem quadrupole MS (Waters Corporation, Milford, 343 
MA, USA). The UPLC/MS system was controlled by Micromass MassLynx 4.0 (Waters Corporation, 344 
Milford, MA, USA). The UPLC conditions were described previously (Sato et al., Plant Cell Physiol. 345 
2011; 52: 509-517). The MS parameters for the detection of OPDA-Ile were set according to the 346 
method described by Floková et al. (Phytochemistry. 2016; 122: 230–237). OPDA-[13C6,15N]Ile was 347 
used as a standard for quantitative analysis. 348 
 349 
7. Analysis of LA-Ile (10) 350 
A. thaliana plants were grown according to the method described in the previous section. Plants 351 
(500 mg) were then extracted with 10 ml of an 80% aqueous MeOH solution. The resulting extract 352 
was applied onto a C18 solid phase extraction cartridge (Bond Elut, 6 ml, Agilent Technologies, CA, 353 
USA) that had been equilibrated with 80% aqueous MeOH. After the cartridge was washed with 6 ml 354 
of 80% MeOH, LA-Ile (10) was eluted with 6 ml of MeOH. The eluate was evaporated, and the 355 
obtained residue was dissolved in 500 l of 80% aqueous MeOH for analysis. The detection and 356 
quantification of LA-Ile (10) were performed using a 4000Q TRAP LC-MS/MS system (Sciex, 357 
Framingham, MA, USA) equipped with an electrospray ionization (ESI) source (turbo V) and 1290 358 
Infinity HPLC system (Agilent, Santa Clara, CA, USA). Chromatographic separation was 359 
performed at 40 °C on a TSK-gel ODS-100V column (150 mm × 2 mm inner diameter (i.d.), 5 µm) 360 
(Tosoh Corporation, Tokyo, Japan). Eluents were composed of water/formic acid (99.9/0.1, v/v) 361 
 
 
(eluent A) and methanol/formic acid (99.9/0.1, v/v) (eluent B). Elution was conducted at a flow rate 362 
of 0.20 ml/min with the following linear gradient: 0–3 min, 50% B; 3–18 min, 50–97% B; 18–22 min, 363 
97% B; 22–22.1 min, 97–50% B; and 22.1–29 min, 50% B. The injection volume was 10 μl. MS data 364 
were acquired in multiple reaction monitoring (MRM) mode. The conditions of the interface were as 365 
follows: ion spray voltage, −4500 V; source temperature, 450 °C; curtain gas pressure, 10 psi; 366 
nebulizing gas pressure, 70 psi; and turbo gas pressure, 80 psi. The parameters used for the mass 367 
spectrometry of LA-Ile (10) are listed in Supplemental Table S1. Analyst 1.6.2 software was used for 368 
data acquisition and processing. LA-[13C6,15N]Ile was used as a standard for quantitative analysis. The 369 
values given are the mean ± SD of five independent biological replicates. 370 
 371 
8. In vitro synthesis of OPDA-Ile (9) by an A. thaliana protein extract  372 
Plants (1.0 g) were ground in liquid nitrogen and extracted with 10 ml of 100 mM sodium 373 
phosphate buffer (pH 7.8). The residue was removed by centrifugation at 20,000 × g for 15 min, 374 
and the supernatant was then used as a protein extract to synthesize OPDA-Ile (9). One milliliter of 375 
the protein extract supplemented with 1 mM LA-Ile (10) was incubated at 25 °C for 1 hour. The pH 376 
of the reaction solution was adjusted to approximately 3, and the solution was next extracted with an 377 
equal volume of ethyl acetate and then evaporated. The resulting residue was dissolved in 200 l of 378 
80% aqueous MeOH, and OPDA-Ile (9) was analyzed by UPLC-MS/MS according to the method 379 
described above. A protein extract without added LA-Ile (10) and 100 mM sodium phosphate buffer 380 
(pH 7.8) supplemented with LA-Ile (10) were used as controls. 381 
 382 
 383 
 384 
 385 
 386 
 387 
 388 
 389 
 
 
 390 
 391 
Supplemental Fig. S1. 1H-NMR spectrum of OPDA-Ile (9) (270 MHz, CDCl3). 392 
 393 
 394 
Supplemental Fig. S2. 13C-NMR spectrum of OPDA-Ile (9) (67.5 MHz, CDCl3). 395 
 
 
 396 
Supplemental Table S1. Optimized MS parameters for the analysis of LA-Ile. 397 
Compound 
Scan 
mode 
MRM 
transition 
Declustering 
potential (V) 
Entrance 
potential 
(V) 
Collision 
energy 
(V) 
Collision 
exit 
potential 
(V) 
LA-Ile – 390.3/128.0 -80 -10 -34 -19 
 398 
